Polyrizon
Ra'anana
About Polyrizon
Polyrizon is a biotechnology company that develops intranasal medical products. It focuses on hydrogel-based nasal spray technologies that form protective barriers in the nasal cavity and enable intranasal delivery of active pharmaceutical ingredients. Its product development includes allergy, viral, and therapeutic delivery applications based on proprietary platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $17.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2025)
- Ticker: nasdaq:PLRZ
- Website: polyrizon-biotech.com
- Phone: +972 055-433-5665
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/polyrizon-91777 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.